Pfizer (PFE) said late Friday it is advising shareholders not to participate in Tutanota's unsolicited mini-tender offer to purchase up to 1 million shares at $32 each.
Pfizer said the offer is conditioned on its stock closing above $32 and is subject to multiple conditions, including Tutanota obtaining financing, which it does not currently have. The company added that shareholders could receive below-market value if certain conditions are waived.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments